These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22378016)

  • 1. In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T.
    Flament J; Geffroy F; Medina C; Robic C; Mayer JF; Mériaux S; Valette J; Robert P; Port M; Le Bihan D; Lethimonnier F; Boumezbeur F
    Magn Reson Med; 2013 Jan; 69(1):179-87. PubMed ID: 22378016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
    McVicar N; Li AX; Meakin SO; Bartha R
    NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.
    Chahid B; Vander Elst L; Flament J; Boumezbeur F; Medina C; Port M; Muller RN; Lesieur S
    Contrast Media Mol Imaging; 2014; 9(6):391-9. PubMed ID: 24760773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
    Schmieder AH; Winter PM; Caruthers SD; Harris TD; Williams TA; Allen JS; Lacy EK; Zhang H; Scott MJ; Hu G; Robertson JD; Wickline SA; Lanza GM
    Magn Reson Med; 2005 Mar; 53(3):621-7. PubMed ID: 15723405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
    Shan X; Yuan D; Xiong F; Gu N; Wang P
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles.
    Giraudeau C; Geffroy F; Mériaux S; Boumezbeur F; Robert P; Port M; Robic C; Le Bihan D; Lethimonnier F; Valette J
    Angiogenesis; 2013 Jan; 16(1):171-9. PubMed ID: 23053783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Magnetonanoparticles Conjugated with New Angiogenesis Peptides in Intracranial Glioma Tumors by MRI.
    de Oliveira EA; Lazovic J; Guo L; Soto H; Faintuch BL; Akhtari M; Pope W
    Appl Biochem Biotechnol; 2017 Sep; 183(1):265-279. PubMed ID: 28281182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
    Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
    Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-based chemical exchange saturation transfer (CEST) agents.
    Castelli DD; Terreno E; Longo D; Aime S
    NMR Biomed; 2013 Jul; 26(7):839-49. PubMed ID: 23784956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes.
    Delli Castelli D; Dastrù W; Terreno E; Cittadino E; Mainini F; Torres E; Spadaro M; Aime S
    J Control Release; 2010 Jun; 144(3):271-9. PubMed ID: 20230865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.
    Huo T; Du X; Zhang S; Liu X; Li X
    Eur J Radiol; 2010 Feb; 73(2):420-7. PubMed ID: 19261416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
    Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
    J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo.
    Kluza E; Jacobs I; Hectors SJ; Mayo KH; Griffioen AW; Strijkers GJ; Nicolay K
    J Control Release; 2012 Mar; 158(2):207-14. PubMed ID: 22079810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
    Schmieder AH; Caruthers SD; Zhang H; Williams TA; Robertson JD; Wickline SA; Lanza GM
    FASEB J; 2008 Dec; 22(12):4179-89. PubMed ID: 18697838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency-encoded MRI-CEST agents based on paramagnetic liposomes/RBC aggregates.
    Ferrauto G; Di Gregorio E; Baroni S; Aime S
    Nano Lett; 2014 Dec; 14(12):6857-62. PubMed ID: 25371974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LipoCEST and cellCEST imaging agents: opportunities and challenges.
    Ferrauto G; Delli Castelli D; Di Gregorio E; Terreno E; Aime S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):602-18. PubMed ID: 26810631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Characterization of Novel LipoCEST Agents Based on Thermosensitive Liposomes.
    Maruyama S; Ueda J; Kimura A; Murase K
    Magn Reson Med Sci; 2016 Jul; 15(3):324-34. PubMed ID: 26841852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.